4//SEC Filing
MANNING JOSEPH J 4
Accession 0001415889-22-009123
CIK 0000001800other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:46 PM ET
Size
10.8 KB
Accession
0001415889-22-009123
Insider Transaction Report
Form 4
MANNING JOSEPH J
Senior Vice President
Transactions
- Exercise/Conversion
Option (right to buy)
2022-08-25−23,008→ 23,008 totalExercise: $44.40From: 2020-02-17Exp: 2027-02-16→ Common Shares (23,008 underlying) - Sale
Common shares without par value
2022-08-25$105.24/sh−3,890$409,384→ 53,245 total - Exercise/Conversion
Common shares without par value
2022-08-25$44.40/sh+23,008$1,021,555→ 80,143 total - Sale
Common shares without par value
2022-08-25$104.99/sh−23,008$2,415,704→ 57,135 total
Footnotes (3)
- [F1]Since the date of the reporting person's last ownership report, he transferred 3,738 shares and employee stock options to purchase 69,500 shares in the aggregate to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.59 to $105.37, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001695686
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:46 PM ET
- Size
- 10.8 KB